Baker Tisch Capital , Llc Insider Profile
4 Followers
Baker Tisch Capital , Llc, Ten Percent Owner at Heron Therapeutics, holds 450.46K shares in Seagen (Ticker: SGEN), holds 206.80K shares in Synageva (Ticker: GEVA), holds 67.32K shares in Auxilium (Ticker: AUXL). Most recently, Baker Tisch Capital , Llc Bought ― shares of Seagen on Jan 04, 2012 for an estimated value of $309.77K.
Baker Tisch Capital , Llc's Trading History
| SGENSeagen | Jan 04, 2012 | ― | Informative Buy | 309.77K | $103.04M | |
| GEVASynageva | Nov 04, 2011 | ― | Uninformative Buy | ― | ― | |
| AUXLAuxilium | Aug 03, 2011 | ― | Informative Sell | 155.56K | ― | |
| INCYIncyte | Sep 23, 2010 | Director, Ten Percent Owner | Informative Sell | 321.63K | $19.11M | |
| HRTXHeron Therapeutics | Oct 28, 2009 | Ten Percent Owner | Informative Buy | ― | $1.75K | |
| BCRXBioCryst | Jun 01, 2009 | Ten Percent Owner | Informative Sell | 42.54K | $132.58K | |
| GHDXGenomic Health | May 22, 2009 | ― | Informative Buy | 1.62K | $12.32M | |
| VPHMViropharma | May 08, 2009 | ― | Informative Buy | ― | ― |
You May Also Like
Baker Tisch Capital , Llc insider profile FAQ
What is the percentage of profitable transactions made by Baker Tisch Capital , Llc?
The percentage of profitable transactions made by Baker Tisch Capital , Llc is 46%.
What is the average return per transaction made by Baker Tisch Capital , Llc?
The average return per transaction made by Baker Tisch Capital , Llc is 63.10%.
What stocks does Baker Tisch Capital , Llc hold?
Baker Tisch Capital , Llc holds: HRTX, SGEN, INCY, GHDX, BCRX, AUXL, GEVA, VPHM stocks.
What was Baker Tisch Capital , Llc’s latest transaction?
Baker Tisch Capital , Llc’s latest transaction was an Informative Buy of $309.77K.
What was Baker Tisch Capital , Llc's most profitable transaction?
Baker Tisch Capital , Llc’s most profitable transaction was an Informative Buy of INCY stock on March 5, 2009. The return on the trade was 439.50%.
What is Baker Tisch Capital , Llc's role in Heron Therapeutics?
Baker Tisch Capital , Llc's role in Heron Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
